Open Orphan Plc (LON:ORPH – Get Free Report)’s share price rose 5.3% on Tuesday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). Approximately 652,639 shares were traded during trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Price Performance
The company has a market capitalization of £67.09 million and a P/E ratio of -25.30. The company has a debt-to-equity ratio of 10.88, a current ratio of 1.19 and a quick ratio of 1.16. The company has a 50 day moving average of GBX 10 and a 200-day moving average of GBX 10.
Open Orphan Company Profile
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than Open Orphan
- Roth IRA Calculator: Calculate Your Potential Returns
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What Is WallStreetBets and What Stocks Are They Targeting?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.